Amgen, Softbank-backed Neumora files for IPO in US



Neumora Therapeutics, a biopharmaceutical company supported by Amgen Inc. and SoftBank Group, filed for an initial public offering of its stock in New York.

“We have applied to list our common s…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento